Cytokine modulation of basophil histamine release in wasp-venom allergy. 1994

M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
Department of Respiratory Medicine, CHU Sart Tilman, University of Liège, Belgium.

We report the effect of interleukin-3 (IL-3) and of other cytokines on antigen-induced basophil histamine release in wasp-venom-allergic subjects. Leukocytes from 12 patients with documented anaphylactic sensitivity to wasp venom were preincubated in the presence or absence of IL-3, granulocyte/macrophage-colony stimulating factor (GM-CSF), IL-5, IL-8, or stem cell factor (SCF). Washed cells were then exposed to venom and to other secretagogues, and histamine release in the supernatant was measured fluorometrically. Preincubation of leukocytes with IL-3, GM-CSF, or IL-5 (0.02-2 ng/ml), but not with IL-8 and SCF, caused a dose-dependent enhancement of antigen-induced basophilic histamine release in all subjects tested. Mean maximum increase was about 100% for IL-3, IL-5, and GM-CSF. The priming effect of IL-3 was rapid, persisted up to 12 h, and was not accompanied by a change in cellular histamine. IL-3 had a comparable enhancing effect when basophils were triggered with anti-IgE or N-formylmethionylphenylalanine (FMP). By contrast, IL-3 had no effect on substance-P-induced histamine release. The significant enhancement of basophil releasability to antigen in wasp-venom allergy by very low concentrations of IL-3, GM-CSF, and IL-5 suggests that cytokines in the basophil (mast-cell?) microenvironment could be critical factors in determining the variability of sting reactions in Hymenoptera-venom-allergic subjects.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005260 Female Females
D006636 Histamine Release The secretion of histamine from mast cell and basophil granules by exocytosis. This can be initiated by a number of factors, all of which involve binding of IgE, cross-linked by antigen, to the mast cell or basophil's Fc receptors. Once released, histamine binds to a number of different target cell receptors and exerts a wide variety of effects. Histamine Liberation,Histamine Liberations,Histamine Releases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000707 Anaphylaxis An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death. Anaphylactic Reaction,Anaphylactoid Reaction,Anaphylactoid Shock,Shock, Anaphylactic,Anaphylactic Reactions,Anaphylactic Shock,Anaphylactoid Reactions,Reaction, Anaphylactic,Reaction, Anaphylactoid,Shock, Anaphylactoid

Related Publications

M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
February 1988, Allergy,
M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
January 2015, Cytometry. Part B, Clinical cytometry,
M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
August 2014, Cytometry. Part B, Clinical cytometry,
M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
January 1992, Immunology series,
M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
January 2015, Cytometry. Part B, Clinical cytometry,
M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
March 2003, Cytometry. Part B, Clinical cytometry,
M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
September 1989, Allergy,
M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
August 1987, Anaesthesia,
M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
October 1985, Revue medicale de Liege,
M Radermecker, and R Louis, and M Leclercq, and T Weber, and J L Corhay, and T Bury
October 2004, Allergy,
Copied contents to your clipboard!